Related Articles
Baseline neutrophil‑to‑lymphocyte ratio predicts the prognosis of castration‑resistant prostate cancer treated with abiraterone acetate
Treatment sequence in castration-resistant prostate cancer: A retrospective study in the new anti-androgen era
Clinical predictor of survival following docetaxel‑based chemotherapy
Efficacy of abiraterone combined with flutamide on prostate cancer patients and its effect on serum miR-493-5p and miR-195-5p
Risk stratification of castration‑resistant prostate cancer patients treated with cabazitaxel